HKEX Stock Code: 01093English|繁體|简体

2025Q1 Results

  • Revenue RMB7,015M, -21.9%
  • Reported profit attributable to shareholders of the Company RMB1,478M, -8.4%
  • Underlying profit attributable to shareholders of the Company RMB1,411M, -18.2%
  • Basic earnings per share (based on reported profit) RMB12.91 cents, -5.1%
  • Basic earnings per share (based on underlying profit) RMB12.32 cents, -15.3%

Highlight - 2025Q1 Results

Revenue
RMB7,015M, -21.9%
Reported profit attributable to shareholders of the Company
RMB1,478M, -8.4%
Underlying profit attributable to shareholders of the Company
RMB1,411M, -18.2%
Basic earnings per share (based on reported profit)
RMB12.91 cents, -5.1%
Basic earnings per share (based on underlying profit)
RMB12.32 cents, -15.3%

Corporate Governance

Corporate Governance

Financial Calendar

May
30
May
29
May
29
Mar
28
Mar
28

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.